Skip to content

A Clinical Trial to study the effect of Unani formulation in the patient of fungal infection of the skin.

Therapeutic evaluation of Post Beikh-e Kibr and Sirka in Bahaq (Pityriasis Versicolor)- A Randomized Single Blind standard controlled study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/09/009842
Enrollment
40
Registered
2017-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Bahaq (Pityriasis Versicolor)

Interventions

Intervention1: 1. Post Beikh-e Kibr (Caparis spinosa)- As required 2. Sirka (Vinegar) - Quantity Sufficient (QS) : After making fine powder of Post Beikh-e Kibr,Vinegar

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed patients of Bahaq 2. Patients in the age group of 18 to 60 years 3. Patients who have agreed to sign the informed consent form and follow the protocol

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women 2. Patients below and above the age of 18 and 60 years respectively 3. Patient suffering from other concomitant skin diseases like vitiligo, psoriasis, dermatophytosis and eczema 4. Unwillingness or inability to fulfill the protocol

Design outcomes

Primary

MeasureTime frame
Primary outcome measure was mycological cure rate of KOH examination of skin scrap (Direct Microscopy).Timepoint: At the end of 28 days

Secondary

MeasureTime frame
Secondary outcome measure was improvement in subjective parameters (Hypopigmentation, Scaling and Itching) of skin lesions. evaluated by an arbitrary grading scale; Total Sign and Symptom Score (TSSS) assessed on four point scale (0- absent; 1- mild; 2- moderate; 3- severe).Timepoint: 28 days

Countries

India

Contacts

Public ContactMohammad Ali

Aligarh Muslim University

tanzeel_ahmad@rediffmail.com9448347809

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026